CNine Biosolutions, LLC, Birmingham, AL, United States.
Department of Life Sciences, Imperial College London, London, United Kingdom.
Front Immunol. 2020 Nov 10;11:585108. doi: 10.3389/fimmu.2020.585108. eCollection 2020.
The soluble membrane attack complex (sMAC, a.k.a., sC5b-9 or TCC) is generated on activation of complement and contains the complement proteins C5b, C6, C7, C8, C9 together with the regulatory proteins clusterin and/or vitronectin. sMAC is a member of the MACPF/cholesterol-dependent-cytolysin superfamily of pore-forming molecules that insert into lipid bilayers and disrupt cellular integrity and function. sMAC is a unique complement activation macromolecule as it is comprised of several different subunits. To date no complement-mediated function has been identified for sMAC. sMAC is present in blood and other body fluids under homeostatic conditions and there is abundant evidence documenting changes in sMAC levels during infection, autoimmune disease and trauma. Despite decades of scientific interest in sMAC, the mechanisms regulating its formation in healthy individuals and its biological functions in both health and disease remain poorly understood. Here, we review the structural differences between sMAC and its membrane counterpart, MAC, and examine sMAC immunobiology with respect to its presence in body fluids in health and disease. Finally, we discuss the diagnostic potential of sMAC for diagnostic and prognostic applications and potential utility as a companion diagnostic.
可溶性膜攻击复合物(sMAC,又名 sC5b-9 或 TCC)在补体激活时产生,包含补体蛋白 C5b、C6、C7、C8、C9 以及调节蛋白簇蛋白和/或 vitronectin。sMAC 是 MACPF/胆固醇依赖性细胞溶解素超家族的孔形成分子之一,该超家族的分子插入脂质双层并破坏细胞完整性和功能。sMAC 是一种独特的补体激活大分子,因为它由几个不同的亚基组成。迄今为止,尚未发现 sMAC 具有补体介导的功能。sMAC 在稳态条件下存在于血液和其他体液中,有大量证据表明在感染、自身免疫性疾病和创伤期间 sMAC 水平发生变化。尽管科学界对 sMAC 感兴趣已有数十年,但调节其在健康个体中形成的机制及其在健康和疾病中的生物学功能仍知之甚少。在这里,我们回顾了 sMAC 与其膜对应物 MAC 之间的结构差异,并研究了 sMAC 免疫生物学,包括其在健康和疾病状态下体液中的存在。最后,我们讨论了 sMAC 作为诊断和预后应用的诊断潜力以及作为伴随诊断的潜在用途。